Pedro P. Granadillo, Director at NOVEN PHARMACEUTICALS INC (NOVN), bought 5,000 shares at $9.89 ($49K) on 2008-05-13, disclosed to the SEC on 2008-05-15.
Open-market purchase of $49k NOVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2017-12-04 | $429K | — | Filing → |
| HAE | SELL | 2015-02-19 | $492K | — | Filing → |
| HAE | SELL | 2014-07-08 | $210K | — | Filing → |